Recurrence of cardiovascular events in patients with type 2 diabetes: Epidemiology and risk factors

Diabetes Care

Volumn 31, Issue 11, 2008, Pages 2154-2159

  Giorda, Carlo B ^a   Avogaro, Angelo ^b   Maggini, Marina ^c   Lombardo, Flavia ^c   Mannucci, Edoardo ^d   Turco, Salvatore ^e   Alegiani, Stefania Spila ^d   Raschetti, Roberto ^d   Velussi, Mario ^f   Ferrannini, Ele ^g  

^a Metabolism and Diabetes Unit   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^d CAREGGI UNIVERSITY HOSPITAL   (Italy)

^e UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^f Casa di Cura Pineta del Carso   (Italy)

^g CNR   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; INSULIN; ORAL ANTIDIABETIC AGENT; TRIACYLGLYCEROL;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLINDNESS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONTROLLED STUDY; DIABETIC DIET; DIABETIC FOOT; DIABETIC PATIENT; DIABETIC RETINOPATHY; DISEASE DURATION; DISEASE SURVEILLANCE; FAMILIAL DISEASE; FEMALE; GLYCEMIC CONTROL; HEART INFARCTION; HIGH RISK PATIENT; HUMAN; HYPERTENSION; INCIDENCE; INSULIN TREATMENT; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OUTPATIENT DEPARTMENT; RECURRENT DISEASE; RISK ASSESSMENT; SENESCENCE; SEX DIFFERENCE; SMOKING; STROKE; TRIACYLGLYCEROL BLOOD LEVEL; ITALY; MIDDLE AGED; RISK FACTOR;

ADULT; AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; ANTILIPEMIC AGENTS; CARDIOVASCULAR DISEASES; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INCIDENCE; ITALY; MALE; MIDDLE AGED; OBESITY; RISK FACTORS; SMOKING;

EID: 59249098089     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc08-1013     Document Type: Article

References (24)

1. Abbott RD, Donahue RP, Kannel WB, Wilson PW: The impact of diabetes on survival following myocardial infarction in men vs. women: the Framingham Study. JAMA 260:3456-3460, 1988
2. Miettinen H, Lehto S, Salomaa VV, Mähönen M, Niemela M, Haffner SM, Pyörälä K, Tuomilheto J: Impact of diabetes on mortality after the first myocardial infarction: the FINMONICA Myocardial Infarction Register Study Group. Diabetes Care 21:69-75, 1998
3. Haffner SM, Lehto S, Rönnemaa T, Pyörälä K, Laakso M: Mortality form coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 339:229-234, 1998
4. Erdmann E, Dormandy JA, Charbonnel B, Massi-Benedetti M, Moules IK, Skene AM, PROactive Investigators: The effect of pio- glitazone on recurrent myocardial infarction in 2,445 patients with type 2 diabetes and previous myocardial infarction: results from the PROactive (PROactive 05) study. J Am Coll Cardiol 49:1772-1780, 2007
5. The DAI Study Group: Prevalence of coronary heart disease in a cohort of type 2 diabetic patients in Italy: the DAI study. Diabet Med 21:738-745, 2004
6. Harris MI, Hadden WC, Knowler WC, Bennett PH: International criteria for the diagnosis of diabetes and impaired glucose tolerance. Diabetes Care 8:562-567, 1985
7. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 344:1383-1389, 1994
8. Strandberg TE, Pitkala KH, Berglind S Ni- eminen MS, Tilvis RS: Multifactorial intervention to prevent recurrent cardiovascular events in patients 75 years or older: the Drugs and Evidence-Based Medicine in the Elderly (DEBATE) study: a randomized, controlled trial. Am Heart J 152:585-592, 2006
9. Lichtman JH, Krumholz HM, Wang Y, Radford MJ, Brass LM: Risk and predictors of stroke after myocardial infarction among the elderly: results from Cooperative Cardiovascular Project. Circulation 105:1082-1087, 2002
10. Croxson SC, Burden AC, Bodington M, Botha JL: The prevalence of diabetes in elderly people. Diabet Med 8:28-31, 1991
11. Murabito JM, Evans JC, Larson MG, Levy D: Prognosis after the onset of coronary heart disease: an investigation of differences in outcome between the sexes according to initial coronary disease presentation. Circulation 88:2548-2555, 1993
12. Avogaro A, Giorda C, Maggini M, Man- nucci E, Raschetti R, Lombardo F, Spila- Alegiani S, Turco S, Velussi M, Ferrannini E: Incidence of coronary heart disease in type 2 diabetic men and women: impact of microvascular complications, treatment, and geographic location. Diabetes Care 30:1241-1247, 2007
13. Giorda CB, Avogaro A, Maggini M, Lom- bardo F, Mannucci E, Turco S, Alegiani SS, Raschetti R, Velussi M, Ferrannini E, DAI Study Group: Incidence and risk factors for stroke in type 2 diabetic patients: the DAI study. Stroke 38:1154-1160, 2007
14. Stone PH, Thompson B, Anderson HV, Kronenberg MW, Gibson RS, Rogers WJ, Diver DJ, Theroux P, Warnica JW, Na- smith JB, Kells C, Kleiman N, McCabe CH, Schactman M, Knatterud GL, Braun- wald E: Influence of race, sex, and age on management of unstable angina and non- Q-wave myocardial infarction: the TIMI III registry. JAMA 275:1104-1112, 1996
15. Frishman WH, Gomberg-Maitland M, Hirsch H, Catanese J, Furia-Palazzo S, Mueller H, Steingart R, Forman S: Differences between male and female patients with regard to baseline demographics and clinical outcomes in the Asymptomatic Cardiac Ischemia Pilot (ACIP) trial. Clin Cardiol 21:184-190, 1998
16. Wang S-L, Head J, Stevens L, Fuller JH, WHO Multinational Study Group: Excess mortality and its relation to hypertension and proteinuria in diabetic patients: the WHO multinational studyofvascular disease in diabetes. Diabetes Care 19:305-312, 1996
17. Rosengren A, Wilhelmsen L, Hagman M, Wedel H: Natural history of myocardial infarction and angina pectoris in a general population sample of middle-aged med: a 16-year follow-up of the Primary Prevention Study, Goteborg, Sweden. J Intern Med 244:495-505, 1998
18. Lampe FC, Whincup PH, Wannamethee SG, Shaper AG, Walker M, Ebrahim S: The natural history of prevalent ischaemic heart disease in the middle-aged men. Eur HeartJ 21:1052-1062, 2000
19. Kronmal RA, Barzilay JI, Smith NL, Psaty BM, Kuller LH, Burke GL, Furberg C: Mortality in pharmacologically treated older adults with diabetes: the Cardiovascular Health Study, 1989-2001. PLoS Med 3:e424, 2006
20. Kronmal RA, Barzilay JI, Tracy RP, Savage PJ, Orchard TJ, Burke GL: The relationship of fasting serum radioimmune insulin levels to incident coronary heart disease in an insulin-treated diabetic cohort. J Clin Endocrinol Metab 89:2852-2858, 2004
21. Delgado-Rodriguez M, Llorca J Bias. J: Epidemiol CommunityHealth58:635-641, 2004
22. Mamdani M, Sykora K, Li P, Normand SL, Streiner DL, Austin PC, Rochon PA, Anderson GM: Reader's guide to critical appraisal of cohort studies: 2. Assessing potential for confounding. BMJ 330:960-962, 2005
23. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCTT/EDIC) Study Research Group: Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 353:2643-2653, 2005
24. Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, Hadden D, Turner RC, Holman R: Association of gly- caemia with macrovascular and microvas- cular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 321:405-412, 2000